Gamlen Tableting Ltd Shortlisted for Medilink East Midlands Business Award

Medilink East Midlands has announced it's Business Awards Shortlist for 2011 and
Michael Gamlen has been selected as a finalist, in the Innovation Award categor
y, at the Innovation Day Awards Dinner to be held on the 11th May.
Staffordshire, UK, April 27, 2011 -- Gamlen Tableting Ltd's shortlisted entry is
for the Gamlen Tableting Press, the world's first bench top, computer controlle
d tablet machine, and the owner and developer, Dr Michael Gamlen, would see winn
ing the award as recognition of the many years of hard work to bring the product
to market.
This unique bench top, computer controlled tablet machine (patent applied for) o
ffers almost unlimited applications in the pharmaceutical industry, as well as p
otential in markets such as the nuclear, medical diagnostics, ceramics and nanom
olecular industries. Its true value lies in its ability to make a compact under
very tightly controlled conditions at a specified compaction pressure or thickn
ess, a process that normally requires a large machine costing hundreds of thousa
nds of pounds.
It can also be used to study repeated compaction events on the same sample, a un
ique capability on small scale equipment. The high degree of control produces t
ablets with better uniformity than is possible using a conventional tablet press
. The machine can be used to make small tablets and evaluate very small amounts
of material (as little as 10mg) making it specifically relevant for micro-table
ting requirements.
The Press can also be used to make multilayered tablets with the compression for
ce for each layer being controlled independently. This facilitates the direct s
tudy of the effect of composition on layer binding properties, which is extremel
y difficult to do using conventional equipment.
The launch of the Gamlen Tablet Press comes off the back of Dr Michael Gamlen's
35 years experience in tableting, but also with various support from external so
urces. Commenting on this Dr Michael Gamlen said: â Without the financial backing,
in the form of innovation support funding, from the Bioscience iNet and the help
and support from Medilink East Midlands and UK Trade and Investment, the potent
ial for the Gamlen Tablet Press may not have been realised, so for this I am ver
y gratefulâ .
Asked to comment on what it would mean to the business if the Gamlen Tableting P
ress secured the winning vote in the final, he added: â I see this potential award a
s a springboard for the product and a platform from which we could exploit its g
reat potential in the UK and global pharmaceutical markets. I truly believe tha
t the Gamlen Tablet Press can shorten pharmaceutical development life cycle time
s, and improve quality control of tableted products. Every pharmaceutical compa
ny in the world which develops or manufactures tablets would benefit from using
themâ .
To sum up why the Gamlen Tablet Press should win the prestigious award in May he
concluded: â Because it is an example of great British engineering that could make
a major difference in the tableting worldâ .
The awards will be held on the 11th May at the East Midlands Conference Centre,
Nottingham. Winners will be voted by the delegates at the Innovation Day Award
Dinner.
contact :
Philippa Bevan
Partner
Accelerate Associates
Standon Old Hall
Standon, Staffordshire ST21 6RB
01782 791199
philippa@accelerate-associates.co.uk
http://www.compressibility.com